Back to Anacor Homepage Developing Drug Candidates Through Boron Chemistry
Infinite Menus, Copyright 2006, OpenCube Inc. All Rights Reserved.
Learn more about boron technology
Pipeline

By exploiting the advantages of our boron chemistry platform, we have discovered and advanced into clinical development several novel and proprietary boron-based product candidates that address attractive market opportunities.

[ View pipeline ]

 
Pipeline Graphic
 
 
New Releases

Monday, March 31, 2014 | Anacor Pharmaceuticals Announces First Patient Enrolled in Phase 3 Trial of AN2728 in Mild-to-Moderate Atopic Dermatitis
Wednesday, March 19, 2014 | Anacor Pharmaceuticals Appoints Paul L. Berns as Chief Executive Officer
Thursday, March 13, 2014 | Anacor Pharmaceuticals Reports 2013 Fourth Quarter and Year-End Financial Results
 
New Releases Graphic
 
 
Scientific Presentations

January 17-22, 2014 - Kohala Coast, HI

2014 Winter Clinical Dermatology Conference

November 13-17, 2013 - Washington, DC

ASTMH 62nd Annual Meeting

October 4-6, 2013 - Newport Beach, CA

Women’s & Pediatric Dermatology Seminar

May 8-11, 2013 - Edinburgh, Scotland

International Investigative Dermatology Meeting

April 25, 2013 - Emeryville, CA

World Malaria Day

October 14-18, 2012 - Dallas, TX

18th North American Regional ISSX

August 16-19, 2012 - Washington, DC

100th National American Podiatric Medical Association Annual Scientific Meeting